Used in research for treating type 2 diabetes and obesity by enhancing insulin sensitivity and leptin signaling. It helps restore normal cellular response to insulin by blocking PTP1B, a protein that negatively regulates insulin and leptin receptors. This inhibition promotes prolonged activation of insulin receptor pathways, leading to improved glucose uptake and metabolic control. Also investigated for potential in cancer therapy, particularly in breast and ovarian cancers where PTP1B is overexpressed. Commonly used in biochemical assays and cell-based studies to probe signaling pathways related to metabolism and growth.